Comparison of Dydrogesterone and GnRH-a Effects After Laparoscopic Surgery in Patients with Stage III and IV Endometriosis

References

• Collinet P, Fritel X, Revel-Delhom C, et al. Management of endometriosis: CNGOF/HAS clinical practice guidelines - Short version. J Gynecol Obstetrics Human Reproduction. 2018;47(7):265–274. doi:10.1016/j.jogoh.2018.06.003
   PubMed Web of Science ®Google Scholar
• Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256. doi:10.1056/NEJMra1810764
   PubMed Web of Science ®Google Scholar
• Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Human Reproduction Open. 2022;2022(2):hoac009. doi:10.1093/hropen/hoac009
   PubMedGoogle Scholar
• Shafrir AL, Farland LV, Shah DK, et al. Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;51:1–15. doi:10.1016/j.bpobgyn.2018.06.001
   PubMed Web of Science ®Google Scholar
• Kiesel L, Sourouni M. Diagnosis of endometriosis in the 21st century. Climacteric. 2019;22(3):296–302. doi:10.1080/13697137.2019.1578743
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014;101(4):927–935. doi:10.1016/j.fertnstert.2014.02.012
   PubMed Web of Science ®Google Scholar
• Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–275. doi:10.1038/nrendo.2013.255
   PubMed Web of Science ®Google Scholar
• Ferrero S, Evangelisti G, Barra F. Current and emerging treatment options for endometriosis. Expert Opin Pharmacother. 2018;19(10):1109–1125. doi:10.1080/14656566.2018.1494154
   PubMed Web of Science ®Google Scholar
• Iwami N, Kawamata M, Ozawa N, et al. New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: a prospective cohort study, comparison of dienogest versus dydrogesterone. Reprod Biol. 2021;21(1):100470. doi:10.1016/j.repbio.2020.100470
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril. 2012;98(3):591–598. doi:10.1016/j.fertnstert.2012.05.031
   PubMed Web of Science ®Google Scholar
• Griesinger G, Tournaye H, Macklon N, et al. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reprod Biomed Online. 2019;38(2):249–259. doi:10.1016/j.rbmo.2018.11.017
   PubMed Web of Science ®Google Scholar
• Ott J, Egarter C, Aguilera A. Dydrogesterone after 60 years: a glance at the safety profile. Gynecol Endocrinol. 2022;38(4):279–287. doi:10.1080/09513590.2021.2016692
   PubMed Web of Science ®Google Scholar
• Schweppe KW. The place of dydrogesterone in the treatment of endometriosis and adenomyosis. Maturitas. 2009;65(Suppl 1):S23–7. doi:10.1016/j.maturitas.2009.11.011
   PubMedGoogle Scholar
• Griesinger G, Blockeel C, Tournaye H. Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard? Fertil Steril. 2018;109(5):756–762. doi:10.1016/j.fertnstert.2018.03.034
   PubMed Web of Science ®Google Scholar
• Taylor PJ, Kredentser JV. Nonsurgical management of minimal and moderate endometriosis to enhance fertility. Int J Fertil. 1992;37(3):138–143.
   PubMedGoogle Scholar
• Trivedi P, Selvaraj K, Mahapatra PD, Srivastava S, Malik S. Effective post-laparoscopic treatment of endometriosis with dydrogesterone. Gynecol Endocrinol. 2007;23(Suppl 1):73–76. doi:10.1080/09513590701669583
   PubMedGoogle Scholar
• Liu S, Xin X, Hua T, et al. Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: a Systematic Review and Meta-Analysis. PLoS One. 2016;11(11):e0166658. doi:10.1371/journal.pone.0166658
   PubMed Web of Science ®Google Scholar
• Ceyhan ST, Onguru O, Fidan U, et al. Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model. Eur J Obstet Gynecol Reprod Biol. 2011;154(1):100–104. doi:10.1016/j.ejogrb.2010.09.003
   PubMed Web of Science ®Google Scholar
• Sukhikh GT, Adamyan LV, Dubrovina SO, Baranov II, Bezhenar VF. Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study. Fertil Steril. 2021;116(6):1568–1577. doi:10.1016/j.fertnstert.2021.07.1194
   PubMed Web of Science ®Google Scholar
• Overton CE, Lindsay PC, Johal B, et al. A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril. 1994;62(4):701–707. doi:10.1016/s0015-0282(16)56991-x
   PubMed Web of Science ®Google Scholar
• Rižner TL, Brožič P, Doucette C, et al. Selectivity and potency of the retroprogesterone dydrogesterone in vitro. Steroids. 2011;76(6):607–615. doi:10.1016/j.steroids.2011.02.043
   PubMed Web of Science ®Google Scholar
• Trivedi N, Chauhan N, Vaidya V. Effectiveness and safety of dydrogesterone in regularization of menstrual cycle: a post-marketing study. Gynecol Endocrinol. 2016;32(8):667–671. doi:10.3109/09513590.2016.1152238
   PubMed Web of Science ®Google Scholar
• Makhmudova GM, Nazhmutdinova DK, Gafarova D, Lukmanova Iu D. Efektivnost na lechenieto s duphaston na zheni prekarali rekonstruktivno-plastichni operatsii pri endometrioza [Efficacy of duphaston treatment in women with endometriosis after reconstructive surgery]. Akusherstvo I Ginekologiia. 2003;42(4):42–46.
   PubMedGoogle Scholar
• Miravet-Valenciano J, Ruiz-Alonso M, Gómez E, Garcia-Velasco JA. Endometrial receptivity in eutopic endometrium in patients with endometriosis: it is not affected, and let me show you why. Fertil Steril. 2017;108(1):28–31. doi:10.1016/j.fertnstert.2017.06.002
   PubMed Web of Science ®Google Scholar
• Nagy B, Szekeres-Barthó J, Kovács GL, et al. Key to Life: physiological Role and Clinical Implications of Progesterone. Int J Mol Sci. 2021;22(20):11039. doi:10.3390/ijms222011039
   PubMed Web of Science ®Google Scholar
• Labarta E, Sebastian-Leon P, Devesa-Peiro A, et al. Analysis of serum and endometrial progesterone in determining endometrial receptivity. Human Reproduction. 2021;36(11):2861–2870. doi:10.1093/humrep/deab184
   PubMed Web of Science ®Google Scholar
• Cahill DJ, Hull MG. Pituitary-ovarian dysfunction and endometriosis. Human reproduction update. Human Reproduction Update. 2000;6(1):56–66. doi:10.1093/humupd/6.1.56
   PubMed Web of Science ®Google Scholar
• Cunha-Filho JS, Gross JL, Bastos de Souza CA, et al. Physiopathological aspects of corpus luteum defect in infertile patients with mild/minimal endometriosis. J Assist Reprod Genet. 2003;20(3):117–121. doi:10.1023/a:1022625106489
   PubMed Web of Science ®Google Scholar
• Arab H, Alharbi AJ, Oraif A, et al. The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage. In j Women’s Health. 2019;11:589–596. doi:10.2147/ijwh.S224159
   Web of Science ®Google Scholar
• Lee HJ, Park TC, Kim JH, Norwitz E, Lee B. The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: a Systematic Review and Meta-Analysis. Biomed Res Int. 2017;2017:3616875. doi:10.1155/2017/3616875
   PubMed Web of Science ®Google Scholar
• Saccone G, Schoen C, Franasiak JM, Scott RT Jr, Berghella V. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Fertil Steril. 2017;107(2):430–438.e3. doi:10.1016/j.fertnstert.2016.10.031
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Giardina I, Clerici G, Brillo E, Gerli S. Progesterone in normal and pathological pregnancy. Horm Mol Biol Clin Investig. 2016;27(1):35–48. doi:10.1515/hmbci-2016-0038
   PubMed Web of Science ®Google Scholar
• Guo H, Lu Q. Efficacy of dydrogesterone on treating recurrent miscarriage and its influence on immune factors: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(10):10971–10985. doi:10.21037/apm-21-2605
   PubMed Web of Science ®Google Scholar
• Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum Reprod Update. 2019;25(5):564–591. doi:10.1093/humupd/dmz018
   PubMed Web of Science ®Google Scholar
• Agostinis C, Balduit A, Mangogna A, et al. Immunological Basis of the Endometriosis: the Complement System as a Potential Therapeutic Target. Front Immunol. 2020;11:599117. doi:10.3389/fimmu.2020.599117
   PubMed Web of Science ®Google Scholar
• Matteo M, Cicinelli E, Neri M, et al. Pro-inflammatory M1/Th1 type immune network and increased expression of TSG-6 in the eutopic endometrium from women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017;218:99–105. doi:10.1016/j.ejogrb.2017.08.014
   PubMed Web of Science ®Google Scholar